ASML's Geopolitical Crosswinds: Pax-Silica and Micron's Signal Duel Over the Chip Titan's Next Move

ASML shares fell 4.77% amid US export control allegations and Dutch alliance, but a strong Micron outlook and analyst upgrades underline resilient AI demand. Stock remains 60% up YTD.

The Dutch lithography giant ended a turbulent week with its shares nursing a 4.77% loss, closing at €1,582.00 on Friday — roughly 7.5% below the all-time high of €1,710.00 touched just days earlier on June 22. The rollercoaster ride reflected a tug-of-war between deepening regulatory risks and a fresh demand signal from the memory-chip sector.

The week’s jitters began with media reports on June 19 that US Trade Secretary Howard Lutnick had confronted ASML managers over an alleged breach of export controls. The accusation: that an EUV lithography machine or specialized transport components may have reached China in violation of restrictions. ASML issued a categorical denial, stating it had never delivered an EUV system or any component specifically designed for one to China, and that the sheer size and support requirements of these machines made clandestine operation virtually impossible.

Two days of heavy selling followed. Then, on Thursday, a reprieve arrived from an unexpected quarter. Micron, the US memory-chip maker, posted strong fiscal third-quarter 2026 results, citing sustained demand for storage products — a direct read-through for ASML’s equipment orders. Semiconductor equipment stocks jumped in pre-market trading, and ASML rallied 2.6%. The gains were partially erased by renewed selling on Friday, leaving the stock well below its record.

Compounding the regulatory noise, the Dutch government officially joined the US-led Pax-Silica alliance on June 23, a move that tightens multilateral coordination on AI hardware security and supply chains. Markets immediately priced in a higher probability of stricter export controls, not only for ASML’s cutting-edge EUV tools but also for its older DUV immersion systems. Making matters worse, the proposed MATCH Act would extend restrictions to software updates, spare parts, and maintenance services for existing Chinese-installed equipment — directly hitting ASML’s service revenue. China accounted for 19% of system sales in the first quarter of 2026, down sharply from 36% in the final quarter of 2025.

Yet the underlying demand narrative remains robust, reinforced by Micron’s numbers. AI infrastructure spending continues to drive chipmakers’ capacity expansion, with long-term take-or-pay agreements supporting plans for 2026 and beyond. Analysts at Bank of America and Wells Fargo raised their price targets on June 22, citing strong order books and AI-driven visibility. JPMorgan had already lifted its target earlier in the month. The consensus view is that ASML’s monopoly on EUV lithography machines — it plans to deliver at least 60 low-NA EUV systems in 2026 and ramp to 80 in 2027 if demand holds — positions it squarely in the path of the AI investment wave.

Technically, the stock remains comfortably above its moving averages: 12.82% above the 50-day average of €1,402.25 and 40.12% above the 200-day average of €1,129.01. Year-to-date, ASML has surged 60.07%. But valuation is starting to attract scrutiny. Morningstar has flagged that the current price already discounts much of the long-term AI potential. With a market cap of nearly €599 billion and an RSI of 54.8, the stock is neither overbought nor cheap. The 52-week low of €593.60 underscores how far the recovery has run.

The single most consequential variable for ASML’s near-term direction is the order book for calendar 2027. Bank of America expects it to be fully filled when the company reports second-quarter 2026 results on July 15. Should ASML confirm that, the market debate could shift from short-term execution to the earnings potential for 2028 — a qualitatively different conversation. The company has guided for Q2 net revenue between €8.4 billion and €9.0 billion and a gross margin of 51% to 52%. The first quarter delivered €8.8 billion in revenue and a 53% gross margin, with full-year 2026 revenue pegged at €36–40 billion.

Between now and the earnings release, the key risk is legislative. Any progress on the MATCH Act or fresh US government statements on DUV export policy could directly undermine the revenue base that the current valuation assumes is secure. The Pax-Silica alliance adds another layer of uncertainty. A weak order intake, margin pressure, or concrete DUV restrictions in the July report would leave considerable downside room, given the stock’s elevation far above all major moving averages. For now, the Micron signal has outweighed the regulatory drag — but that balance remains fragile.